Related references
Note: Only part of the references are listed.Peptide YY Is Critical for Acylethanolamine Receptor Gpr119-Induced Activation of Gastrointestinal Mucosal Responses
Helen M. Cox et al.
CELL METABOLISM (2010)
PYY3-36 and Oxyntomodulin Can Be Additive in Their Effect on Food Intake in Overweight and Obese Humans
Benjamin C. T. Field et al.
DIABETES (2010)
Neuropeptide Y Suppresses Anorexigenic Output from the Ventromedial Nucleus of the Hypothalamus
Melissa J. S. Chee et al.
JOURNAL OF NEUROSCIENCE (2010)
NPY Neuron-Specific Y2 Receptors Regulate Adipose Tissue and Trabecular Bone but Not Cortical Bone Homeostasis in Mice
Yan-Chuan Shi et al.
PLOS ONE (2010)
Obese reversal by a chronic energy restricted diet leaves an increased Arc NPY/AgRP, but no alteration in POMC/CART, mRNA expression in diet-induced obese mice
Yinghua Yu et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
Additive actions of the cannabinoid and neuropeptide Y systems on adiposity and lipid oxidation
L. Zhang et al.
DIABETES OBESITY & METABOLISM (2009)
Critical Interplay Between Neuropeptide Y and Sex Steroid Pathways in Bone and Adipose Tissue Homeostasis
Susan J. Allison et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Comparable effects of moderate intensity exercise on changes in anorectic gut hormone levels and energy intake to high intensity exercise
Shin-ya Ueda et al.
JOURNAL OF ENDOCRINOLOGY (2009)
Role of Dorsomedial Hypothalamic Neuropeptide Y in Modulating Food Intake and Energy Balance
Liang Yang et al.
JOURNAL OF NEUROSCIENCE (2009)
Critical Role of Arcuate Y4 Receptors and the Melanocortin System in Pancreatic Polypeptide-Induced Reduction in Food Intake in Mice
Shu Lin et al.
PLOS ONE (2009)
Differential effect of PYY1-36 and PYY3-36 on gastric emptying in man
A. -B. Witte et al.
REGULATORY PEPTIDES (2009)
A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like peptide-1 and glucose-dependent insulinotropic peptide release
Zhi-Liang Chu et al.
ENDOCRINOLOGY (2008)
Reversal of visceral adiposity in candy-diet fed female Wistar rats by the CB1 receptor antagonist rimonabant
A. W. Herling et al.
INTERNATIONAL JOURNAL OF OBESITY (2008)
Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice
Douglas Osei-Hyiaman et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Expression of peptide YY in human brain and pituitary tissues
Ryo Morimoto et al.
NUTRITION (2008)
Supraphysiological doses of intravenous PYY3-36 cause nausea, but no additional reduction in food intake
Carel W. le Roux et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2008)
Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass
Carel W. le Roux et al.
ANNALS OF SURGERY (2007)
Novel role of Y1 receptors in the coordinated regulation of bone and energy homeostasis
Paul A. Baldock et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Greater bone formation of Y2 knockout mice is associated with increased osteoprogenitor numbers and altered Y1 receptor expression
Pernilla Lundberg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Low-dose pancreatic polypeptide inhibits food intake in man
David R. Jesudason et al.
BRITISH JOURNAL OF NUTRITION (2007)
Combined deletion of Y1, Y2, and Y4 receptors prevents hypothalamic neuropeptide Y overexpression-induced hyperinsulinemia despite persistence of hyperphagia and obesity
En-Ju D. Lin et al.
ENDOCRINOLOGY (2006)
The rise, fall, and resurrection of the ventromedial hypothalamus in the regulation of feeding behavior and body weight
BA King
PHYSIOLOGY & BEHAVIOR (2006)
The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits cell proliferation and increases markers of adipocyte maturation in cultured mouse 3T3 F442A preadipocytes
M Gary-Bobo et al.
MOLECULAR PHARMACOLOGY (2006)
Leptin directly activates SF1 neurons in the VMH, and this action by leptin is required for normal body-weight homeostasis
H Dhillon et al.
NEURON (2006)
Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively
NM Neary et al.
ENDOCRINOLOGY (2005)
Effect of peptide YY3-36 on food intake in humans
L Degen et al.
GASTROENTEROLOGY (2005)
Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects - A double-blind, randomized, controlled trial
K Wynne et al.
DIABETES (2005)
Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity
D Osei-Hyiaman et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Peptide YY(3-36) inhibits gastric emptying and produces acute reductions in food intake in rhesus monkeys
TH Moran et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2005)
Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lepob/Lepob mice
YL Liu et al.
INTERNATIONAL JOURNAL OF OBESITY (2005)
Intravenous infusion of peptide YY(3-36) potently inhibits food intake in rats
PK Chelikani et al.
ENDOCRINOLOGY (2005)
Interaction between GLP-1 and CCK-33 in inhibiting food intake and appetite in men
JP Gutzwiller et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2004)
Metabolic adjustments with the development, treatment, and recurrence of obesity in obesity-prone rats
PS MacLean et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2004)
NPY and Y receptors: lessons from transgenic and knockout models
S Lin et al.
NEUROPEPTIDES (2004)
Oxyntomodulin suppresses appetite and reduces food intake in humans
MA Cohen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Inhibition of food intake in obese subjects by peptide YY3-36
RL Batterham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Gut hormone PYY3-36 physiologically inhibits food intake
RL Batterham et al.
NATURE (2002)
Knockout mice lacking steroidogenic factor 1 are a novel genetic model of hypothalamic obesity
G Majdic et al.
ENDOCRINOLOGY (2002)
Neuropeptide Y, Y-1, Y-2 and Y-4 receptors mediate Y agonist responses in isolated human colon mucosa
HM Cox et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
Chronic administration of neuropeptide Y into the lateral ventricle of C57BL/6J male mice produces an obesity syndrome including hyperphagia, hyperleptinemia, insulin resistance, and hypogonadism
PD Raposinho et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2001)
Does weight loss maintenance become easier over time?
ML Klem et al.
OBESITY RESEARCH (2000)
Share Paper
